نتایج جستجو برای: ciprofloxacin

تعداد نتایج: 10470  

Journal: :medical journal of islamic republic of iran 0
f mansour ghanaie from the department of medicine, guilan university of medical sciences, rasht, ir. iran r nassiri the *division of medical pharmacology and virology, dept. of pharmacology, pittsburg h university, erie, pa, 16509, usa.

0

2012
Essam Ezzeldin Ibrahim Ahmed

Simultaneous co-administration of multiple drugs is highly probable to allow effective treatment of a disease or multiple disease symptoms. Ciprofloxacin antibiotic is in use worldwide and it is possible to be used in cardiovascular patient’s treatment. The objective of this study was to investigate the biochemical and pharmacokinetic interactions between ciprofloxacin and captopril in rats. Th...

Journal: :Antimicrobial agents and chemotherapy 1992
K P Fu S C Lafredo B Foleno D M Isaacson J F Barrett A J Tobia M E Rosenthale

The antibacterial activity of levofloxacin was compared with those of ofloxacin, ciprofloxacin, and other antibiotics. In general, levofloxacin was equally active or up to fourfold more active than ofloxacin against all 801 organisms tested. Levofloxacin was twofold [corrected] more active than ciprofloxacin against Streptococcus pneumoniae and 2- to 4-fold more active than ciprofloxacin agains...

Journal: :The Journal of antimicrobial chemotherapy 2003
Richard P Spence Kevin J Towner

OBJECTIVES To compare the in vitro activity of moxifloxacin and ciprofloxacin against 226 nosocomial isolates of Acinetobacter baumannii from 44 hospitals in the UK. METHODS MICs of ciprofloxacin and moxifloxacin were determined by Etest. PCR analysis was used to detect chromosomal mutations in the gyrA and parC genes. Isolates resistant to ciprofloxacin and susceptible to moxifloxacin were e...

Journal: :The Journal of antimicrobial chemotherapy 2006
R Gaind B Paglietti M Murgia R Dawar S Uzzau P Cappuccinelli M Deb P Aggarwal S Rubino

OBJECTIVES To define the genetic characteristics and resistance mechanisms of clinical isolates of Salmonella enterica serovar Typhi (S. Typhi) and S. enterica serovar Paratyphi A (S. Paratyphi A) exhibiting high-level fluoroquinolones resistance. METHODS Three S. Typhi and two S. Paratyphi A ciprofloxacin-resistant isolates (MICs > 4 mg/L) were compared with isolates with reduced susceptibil...

Journal: :The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2007
Andrea S Pereira Soraya S Andrade Jussimara Monteiro Helio S Sader Antonio C C Pignatari Ana C Gales

Increasing quinolone resistance has been reported worldwide, mainly among clinical isolates of Escherichia coli. The objectives of this study were to determine the susceptibility profile, the genetic relatedness, and the prevalence of the qnr gene among ciprofloxacin-resistant Escherichia coli isolated from distinct Brazilian hospitals. A total of 144 ciprofloxacin-resistant Escherichia coli we...

2012
Youn-Hwan Hwang Won-Kyung Cho Doorye Jang Jeong-Ho Ha Kiyoun Jung Hyo-In Yun Jin Yeul Ma

Hwangryunhaedok-Tang (HR) and berberine-containing single herbs are used to treat bacterial infection and inflammatory diseases in eastern Asia. The combination of berberine-containing herbal medicines and ciprofloxacin can be an excellent antibacterial chemotherapy against multidrug resistance bacteria. To evaluate the pretreatment effect of berberine and HR, vehicle, berberine (25 and 50 mg/k...

Journal: :Investigative ophthalmology & visual science 1991
G Keren A Alhalel E Bartov R Kitzes-Cohen E Rubinstein S Segev G Treister

To evaluate the penetration of ciprofloxacin, a new wide-spectrum oral antibiotic, into the vitreous, ciprofloxacin was administered orally to 21 patients who were scheduled to undergo vitreal surgery. Seven patients received 750 mg ciprofloxacin 4 hr before surgery (group I), seven patients received this dose 8 hr before surgery (group II), and seven patients received two 750-mg doses of oral ...

Ciprofloxacin is the most commonly used fluoroquinolone. Ciprofloxacin is prescribed for 1 in 44 Americans. Ciprofloxacin is a broad-spectrum bactericidal antibiotic, effective against both gram-positive and gram-negative bacteria, being especially active against the Enterobacteriacae, including many microorganisms resistant to penicillins, cephalosporins and aminoglycosides, and also is effect...

2003
M. A. Channa M. Z. Janjua

Early clinical pharmacology studies of oral and parenteral form of ciprofloxacin were begun shortly after the drug was discovered in Germany in 1982. The clinical trials programme for the efficacy of intravenous ciprofloxacin began in the USA in late 1985 and expanded throughout 1986, 1987 and April 1988. A new drug application for intravenous ciprofloxacin was submitted to the United States Fo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید